REPAGLINIDE (Breckenridge Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the REPAGLINIDE drug offered from Breckenridge Pharmaceutical, Inc.. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | REPAGLINIDE |
SUBSTANCE NAME: | REPAGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-05-01 |
END MARKETING DATE: | 0000-00-00 |
REPAGLINIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | REPAGLINIDE from Breckenridge Pharmaceutical, Inc. |
LABELER NAME: | Breckenridge Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2015-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51991-853_551a2e3b-07a6-4b7a-86ef-215477f09fa9 |
PRODUCT NDC: | 51991-853 |
APPLICATION NUMBER: | ANDA091517 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers: